JESSICA BENCIC: Open Payments
NPI 1821772591 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,840 in 106 payments from 34 companies in 2025. Trend: 2023 $0 · 2024 $901 · 2025 $2,840
Food & beverage: $2,740Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $327 |
| Merck Sharp & Dohme LLC | 12 | $323 |
| Janssen Biotech, Inc. | 10 | $225 |
| Novartis Pharmaceuticals Corporation | 9 | $209 |
| ABBVIE INC. | 9 | $192 |
| Incyte Corporation | 7 | $158 |
| Celgene Corporation | 5 | $139 |
| GENZYME CORPORATION | 4 | $132 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 5 | $96 |
Products named: KEYTRUDA, DATROWAY, MONJUVI, REBLOZYL, IMFINZI, VENCLEXTA, KISQALI, RYTELO.
Industry payments across AZ — which companies pay providers there.
